Vista Capital Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$622K Sell
2,473
-512
-17% -$110K 0.05% 84
2026
Q1
$649K Buy
2,985
+837
+39% +$186K 0.07% 74
2025
Q4
$491K Buy
2,148
+1
+0% +$228 0.05% 93
2025
Q3
$497K Sell
2,147
-88
-4% -$17.9K 0.05% 82
2025
Q2
$415K Buy
2,235
+214
+11% +$39.8K 0.05% 77
2025
Q1
$423K Buy
2,021
+85
+4% +$16.5K 0.05% 62
2024
Q4
$344K Buy
1,936
+762
+65% +$140K 0.04% 79
2024
Q3
$232K Sell
1,174
-40
-3% -$7.46K 0.03% 97
2024
Q2
$208K Buy
1,214
+115
+10% +$19.1K 0.03% 89
2024
Q1
$200K Buy
+1,099
New +$189K 0.03% 93

Other funds holding ABBV

Vista Capital Partners's ABBV Position: Q2 2026 in Review

Vista Capital Partners reduced its AbbVie (ABBV) stake by 17% in Q2 2026, selling an estimated $110K and leaving 2,473 shares worth $622K. The position accounts for 0.05% of the portfolio, ranked #84.

Vista Capital Partners first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $649K in Q1 2026. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vista Capital Partners held 2,473 shares of AbbVie worth $622K as of Q2 2026.
  • Vista Capital Partners sold 512 AbbVie shares in Q2 2026, an estimated $110K.
  • AbbVie made up 0.05% of Vista Capital Partners's portfolio in Q2 2026, its #84 holding.
  • Vista Capital Partners first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • Vista Capital Partners's AbbVie position peaked at $649K in Q1 2026.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vista Capital Partners's 13F filing for Q2 2026, filed 24 Jul 2026.